Tools2h ago
FDA Clears AI Tool For Chemotherapy Decisions
The FDA cleared ArteraAI, the first multimodal AI test designed to determine if breast cancer patients require chemotherapy. The tool analyzes patient data to identify low-risk individuals who can safely avoid toxic treatments. This clearance provides clinicians a validated, data-driven method to personalize oncology care and reduce unnecessary drug exposure for thousands of patients.